ADAM28 and gastric cancer: A study by Yin et al. [58], which used, i.a., Western blot, q-PCR, wound healing assay and flow cytometry, demonstrated ADAM28 overexpression in GC cells, which correlated with shorter overall survival in comparison to those with low ADAM28 expression [58].